Curasan AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other
pharmaceutical manufacturers in Europe:
Nuevolution AB (publ)
sales of 29.73 million Swedish Kronor [US$3.34 million]
Co Don AG
(5.09 million Euro [US$5.53 million]
of which 100%
was Product sales), and
based in the United Kingdom
(£3.25 million [US$3.98 million]
of which 62%
Curasan AG reported sales of 5.62 million Euro (US$6.11 million)
December of 2015.
decrease of 6.2%
versus 2014, when the company's sales were 5.99 million Euro.